Answer
Dexamfetamine sulfate passes into human milk and a risk to newborns or infants cannot be excluded, so a decision must be made whether to stop breastfeeding or discontinue/avoid therapy, weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Amfexa / Dexamfetamine Sulfate Medice 5mg TabletsMedice UK LTD · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked